设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

副总编辑:魏永祥、张运、

罗毅、谭学瑞、唐来坤、

王喜艳

编辑部主任:杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 1 期 第 16 卷

社区卫生服务中心老年糖尿病患者处方多重用药情况分析

Analysis of prescriptions for elderly diabetic patients from community health service centers

作者:申学谦1高绪霞2马立萍2罗冬梅1马玉洁1熊绪臣1祁缘1

英文作者:Shen Xueqian1 Gao Xuxia2 Ma Liping2 Luo Dongmei1 Ma Yujie1 Xiong Xuchen1 Qi Yuan1

单位:1首都医科大学第六临床医学院医学系2016级,北京100029;2首都医科大学附属北京安贞医院全科医疗科100029

英文单位:1Student of Grade 2016 Department of Medicine Sixth Clinical Medical College Capital Medical University Beijing 100029 China; 2Department of General Practice Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

关键词:糖尿病;老年患者;合理用药;多重用药

英文关键词:Diabetesmellitus;Elderlypatients;Rationaldruguse;Polypharmacy 

  • 摘要:
  • 目的 调查北京部分社区卫生服务中心老年糖尿病患者处方中多重用药(≥5/d)发生率,分析多重用药可能原因及降糖药物使用合理性。方法 收集201912112日在首都医科大学附属北京安贞医院4家医联体社区卫生服务中心就诊的60岁及以上老年患者的处方共1 200例,录入处方信息进行描述性分析。结果 1 200例处方中309例为糖尿病患者处方。91例(29.4%)患者存在多重用药,合并疾病种类多、降糖药物使用种类多是影响多重用药的可能原因。降糖药物中单药治疗占57.9%179/309),单药治疗中二甲双胍使用率最高[30.7%55/179)]。新型降糖药物钠-葡萄糖共转运蛋白2抑制剂、胰高血糖素样肽1激动剂、二肽基肽酶4抑制剂在4家社区卫生服务中心较少应用。不同种类降糖药物之间的联合未见不合理应用情况。结论 首都医科大学附属北京安贞医院4家医联体卫生服务中心老年糖尿病患者多重用药比例较高,糖尿病合并多种其他疾病和使用降糖药物种类多是可能的影响因素。糖尿病治疗以传统降糖药物为主,药物应用合理,但是具有心、肾器官保护作用的新型降糖药物应用较少。

  • Objective To investigate the incidence of polypharmacy, possible affecting factors of the polypharmacy (5 kinds/d) and rationality of antidiabetic medicines administration in prescriptions for elderly patients at some community health service centers in Beijing. Methods From December 1st to December 12th, 2019, 1 200 cases of elderly patients aged 60 years and above were collected from four medical union community health service centers of Beijing Anzhen Hospital, Capital Medical University. The prescription information was input for descriptive analysis. Results A total of 1 200 prescriptions were collected, including 309 prescriptions of diabetic patients. There were 91 patients(29.4%) with polypharmacy, and combining with multiple chronic diseases and multiple kinds of hypoglycemic drugs for one patient were the possible factors for the polypharmacy. In hypoglycemic drugs, single drug treatment accounted for 57.9%(179/309) and metformin had the highest utilizationrate30.7%(55/179)] in single drug treatment. The new types of hypoglycemic drugs were rarely prescribed in the four community health service centers, including sodium-glucose co-transporter 2 inhibitor, glucagon-likepeptide-1 agonist and dipeptidyl peptidase 4 inhibitors. No unreasonable use was found in the combination of different kinds of hypoglycemic drugs. Conclusions  There is a high proportion of polypharmac use in elderly patients with diabetes in four medical union community health service centers of Beijing Anzhen Hospital, Capital Medical University. Diabetes complicated with many other diseases and the use of different hypoglycemic drugs are the possible influencing factors. Traditional hypoglycemic drugs are mainly used in the treatment of diabetes mellitus, and the drug application is reasonable. However, the application of new hypoglycemic drugs with cardiac and renal organ protection is rare.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备18043517号-1
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭